3.9 Article

Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Ophthalmology

Ranibizumab for persistent diabetic macular edema after bevacizumab treatment

Gabriel Katz et al.

EUROPEAN JOURNAL OF OPHTHALMOLOGY (2017)

Article Ophthalmology

Conversion to Aflibercept After Prior Anti-VEGF Therapy for Persistent Diabetic Macular Edema

Ehsan Rahimy et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2016)

Article Ophthalmology

EPIRETINAL MEMBRANES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Effect on Outcomes of Anti-vascular Endothelial Growth Factor Therapy

Emine Esra Karaca et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2015)

Article Health Care Sciences & Services

Switching To Less Expensive Blindness Drug Could Save Medicare Part B $18 Billion Over A Ten-Year Period

David Hutton et al.

HEALTH AFFAIRS (2014)

Editorial Material Ophthalmology

Loss of reactivity in intravitreal anti-VEGF therapy: tachyphylaxis or tolerance?

Susanne Binder

BRITISH JOURNAL OF OPHTHALMOLOGY (2012)

Article Endocrinology & Metabolism

Global Prevalence and Major Risk Factors of Diabetic Retinopathy

Joanne W. Y. Yau et al.

DIABETES CARE (2012)

Article Endocrinology & Metabolism

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study)

Pascale Massin et al.

DIABETES CARE (2010)